Current challenges in developing biosimilars

With so many challenges in research, still class of drug is experiencing the maximum funding with great Returns on Investment (ROI). Keeping these points in mind we are organizing the 13th International Conference on Biologics and Biosimilars during October 24-25, 2018 at Boston, USA with the theme: Emerging Trends in Biosimilars Approvals, Market and Pricing.